Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer

Familial Cancer

Volumn 11, Issue 1, 2012, Pages 33-40

  Ståhlbom, Anne Kinhult ^a   Johansson, Hemming ^a   Liljegren, Annelie ^a   Von Wachenfeldt, Anna ^a   Arver, Brita ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

BOADICEA; BRCA1; BRCA2; Breast cancer; Risk assessment

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BREAST AND OVARIAN ANALYSIS OF DISEASE INCIDENCE AND CARRIER ESTIMATION ALGORITHM; BREAST CANCER; CANCER INCIDENCE; CANCER INVASION; CANCER RISK; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC SCREENING; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

ADULT; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HETEROZYGOTE; HUMANS; INCIDENCE; MIDDLE AGED; MODELS, THEORETICAL; MUTATION; MUTATION RATE; PROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE;

EID: 84858290655     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-011-9495-1     Document Type: Article

References (23)

1. Claus EB, Risch N, Thompson WD (1991) Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 48:232-242 (Pubitemid 21891587)
2. Claus EB, Risch N, Thompson WD (1993) The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Breast Cancer Res Treat 28:115-120 (Pubitemid 24056083)
3. Claus EB, Risch N, Thompson WD (1994) Autosomal dominant inheritance of early-onset breast cancer. Implications for risk predictions. Cancer 73:643-651 (Pubitemid 24046606)
4. Parmigiani G, Berry D, Aguilar O (1998) Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62:145-158 (Pubitemid 28093844)
5. Tyrer J, Duffy SW, Cuzick J (2004) A breast cancer prediction model incorporating familial, personal risk factors. Stat Med 23:1111-1130 (Pubitemid 38477070)
6. Antoniou AC, Pharoah PP, Smith P, Easton DF (2004) The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer 91:1580-1590 (Pubitemid 39486366)
7. Antoniou AC, Cunningham AP, Peto J, Evans DG, Lalloo F, Narod SA, Risch HA, Eyfjord JE, Hopper JL, Southey MC, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tryggvadottir L, Syrjakoski K, Kallioniemi OP, Eerola H, Nevanlinna H, Pharoah PD, Easton DF (2008) The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer 98:1457-1466 (Pubitemid 351543573)
8. Antoniou AC, Pharoah PDP, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton- Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjäkoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117-1130 (Pubitemid 36530000)
9. Antoniou AC, Durocher F, Smith P, Simard J, INHERIT BRCAs program members, Easton DF (2006) BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families. Breast Cancer Res 8:R3
10. Antoniou AC, Hardy R, Walker L, Evans DG, Shenton A, Eeles R, Shanley S, Pichert G, Izatt L, Rose S, Douglas F, Eccles D, Morrison PJ, Scott J, Zimmern RL, Easton DF, Pharoah PD (2008) Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinic. J Med Genet 45:425-431 (Pubitemid 351977132)
11. Barcenas CH, Hosain GM, Arun B, Zong J, Zhou X, Chen J, Cortada JM, Mills GB, Tomlinson GE, Miller AR, Strong LC, Amos CI (2006) Assessing BRCA carrier probabilities in extended families. J Clin Oncol 24:354-360 (Pubitemid 46630453)
12. Thirthagiri E, Lee SY, Kang P, Lee DS, Toh GT, Selamat S, Yoon S-Y, Mohd Taib NA, Thong MK, Yip CH, Teo SH (2008) Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer. Breast Cancer Res 10:R59
13. Kurian AW, Gong GD, John EM, Miron A, Felberg A, Phipps A, West DW, Whittenmore AS (2009) Performance of prediction models for BRCA mutation carriage in three racial/ethnic groups: findings from the Northern California breast cancer family registry. Cancer Epidemiol Biomarkers Prev 18:1084-1091
14. BOADICEA http://www.srl.cam.ac.uk/genepi/boadicea/boadicea-home.html. Accessed 7 July 2011
15. The National Oncogenetic Group, Arver B, Einbeigi Z, Loman N, Malander S. 20080901. State-of-the-art. Utredning, uppföljning och omhändertagande av personer med misstänkt ärftlig ökad risk för tumörsjukdom. Bröstcancer och äggstockscancer
16. National Human Genome Research Institute http://research.nhgri.nih.gov/ bic/. Accessed 7 July 2011
17. Mavaddat N, Rebbeck TR, Lakhani SR, Easton DF, Antoniou AC (2010) Incorporating tumour pathology information into breast cancer risk prediction algorithms. Breast Cancer Res 12:R28
18. BOADICEA http://www.srl.cam.ac.uk/genepi/boadicea/boadicea-faqs.html#q32. Accessed 12 July 2011
19. Amir E, Evans DG, Shenton A, Lalloo F, Moran A, Boggis C, Wilson M, Howell A (2003) Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet 40:807-814 (Pubitemid 37485490)
20. Domchek SM, Eisen A, Calzone K, Stopfer J, Blackwood A, Weber BL (2003) Application of breast cancer risk prediction models in clinical practice. J Clin Oncol 21:593-601 (Pubitemid 46621891)
21. Nationella riktlinjer för bröstcancer (national guidelines for breast cancer) http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/ 9085/2007-114-51-200711453.pdf. Accessed 7 July 2011
22. Constantino J, Gail MH, Pee D, Anderson S, Redmond CK, Benichou J, Wieand HS (1999) Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 91:1541-1548 (Pubitemid 29457958)
23. Rockhill B, Spiegelman D, Byrna C, Hunter DJ, Colditz GA (2001) Validation of the Gail et al model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 93:358-366